But weight loss alone does not explain the drugs’ benefits. Both Holst and Sattar pointed to a discontinued GLP-1 drug once ...
Data continue to show that tirzepatide, called Mounjaro for type 2 diabetes and Zepbound for weight loss, is safe and effective, but side effects remain.
Drugs used in hormone therapy for postmenopausal women have beenwrelated with an increase in heart disease and blood clot ...
A nasal spray formulation of bumetanide has been shown to be safe and effective in a new study and could ultimately prevent ...
A recent study from the University of Barcelona found that moderate wine consumption—half to one glass daily—can reduce the ...
Cytokinetics' hopes of resurrecting cardiac myosin activator omecamtiv mecarbil have suffered another setback, after the drug failed to show a benefit in a phase 3 heart failure study. In the ...
Medical Xpress on MSN1 小时
What are pharmacy benefit managers? A health economist explains how lack of competition ...Wegovy and Ozempic are weight loss drugs that promise to transform the treatment of obesity, heart disease and other chronic ...
Congestive heart failure is a disease state distinguished by the regular presence of both renal and hepatic abnormalities in drug handling. One such abnormality involves flaws in the process of ...
A recent study has shown that adding more fruits and vegetables to your diet can significantly lower blood pressure and ...
A recent study from the University of Bologna, published in the journal Hypertension, has uncovered an important finding ...
A drug used to help patients lose weight and manage diabetes may also help those with heart failure, an international clinical trial shows. The test of tirzepatide, brand named Zepbound ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果